Sickle cell gene-editing treatment poised for FDA approval
Listen now
Description
The FDA is close to a decision on a landmark one-time gene-editing treatment for patients with sickle cell disease and another blood disorder. Host Kelly Hooper talks with POLITICO health care reporter Lauren Gardner about how the therapy works, its safety profile, who will be eligible for it and the significant challenges around affordability and access.
More Episodes
Artificial intelligence is changing the way doctors practice, but also how the health care business runs. Host Chelsea Cirruzzo talks with POLITICO health care reporter Daniel Payne about the ways AI is already used across the medical landscape and how regulators are responding.
Published 12/22/23
Published 12/22/23
As federal officials scramble to regulate artificial intelligence in health care, HHS has already become one of the top federal agencies using the technology. Host Kelly Hooper talks with POLITICO health reporter Chelsea Cirruzzo about some of the 80 implemented or planned uses of AI by HHS...
Published 12/21/23
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
